Piramal Healthcare acquires Decision Resources Group
Completes acquisition for approximately Rs 3,400 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ABLE recommends setting up of Rs 5,000 cr biomanufacturing fund
Most therapy solutions in these disease areas are provided by biopharmaceuticals
Strengthening presence in established markets drives M&A activity
The pharmaceutical sector recorded 36 M&A transactions in May 2012, against the previous six months’ average of 54.8…
Pharmexcil to take part in CPhI Worldwide in Madrid
It will also support the Brand India Pharma Campaign
DIA to conduct workshop on imaging in clinical trials
Workshop to be conducted in collaboration with Image Core Lab and Teleradiology Solutions
Good growth, but will it continue?
First the good news. The BSE Healthcare Index has outperformed the overall Sensex in the last two years. Indian pharmaceutical…
Bharat Biotech and CVD receive $ 4 million award
Develops new conjugate vaccine to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella
UNITAID approves $ 30 million for TB test at reduced cost
The US Government and Bill & Melinda Gates Foundation will reduce the price of diagnostic cartridges from $17 to less than $10…
Kenta Biotech develops new treatment option to fight severe S aureus infections
Zurich-based Kenta Biotech announced an important step towards a more efficient treatment of hospital infections.